The vaccines alliance says its First Response Fund could be used to cover the cost of doses and has outlined plans for a vaccine stockpile. Some experts have criticized the slow rate of response to mpox and called for more solidarity on vaccine provision at global level.
Ian Schofield is a journalist whose work has appeared in Informa and The Drum. He covers a wide range of topics in the pharmaceutical and healthcare industries, including regulatory developments, drug approvals, and industry trends. Ian's articles provide valuable insights and analysis for stakeholders in these sectors.